⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL54114 | 1.00 | — | — | |
| SCHEMBL54113 | 1.00 | — | — | |
| SCHEMBL1982375 | 1.00 | — | — | |
| SCHEMBL26181176 | 1.00 | — | — | |
| SCHEMBL2882157 | 1.00 | — | — | |
| SCHEMBL8036234 | 1.00 | — | — | |
| SCHEMBL8050569 | 1.00 | — | — | |
| Lactic Acid SCHEMBL29124696 | 0.95 | TP53 (0.55) | — | |
| Cadaverine Tartrate SCHEMBL29124598 | 0.93 | TSHR (0.48) | — | |
| Succinic Acid SCHEMBL29124662 | 0.91 | CYP1A2 (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120041225-A1 | KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF | VAIDYA NITEEN A (US) | 2012-02-16 | — | — | US | claimed |
| EP-1981831-A2 | KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF | Vaidya, Niteen A. (US) | 2008-10-22 | — | — | EP | claimed |
| WO-2007092264-A2 | KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF | VAIDYA NITEEN A (US) | 2007-08-16 | — | — | WO | claimed |
| US-20070185346-A1 | Kit for automated resolving agent selection and method thereof | VAIDYA NITEEN A | 2007-08-09 | — | — | US | claimed |
| EP-4721735-A1 | COMPOSITION FOR ENTERAL NUTRITION OF CANCER PATIENTS | Kyon Biotech AG (CH) | 2026-04-08 | — | — | EP | disclosed |
| EP-3860584-B1 | COMPOUNDS FOR USE IN PREVENTING OR TREATING ATHLETE OVERTRAINING | TDELTAS LTD (GB) | 2026-02-18 | — | — | EP | disclosed |
| US-20260007157-A1 | 3-HYDROXYBUTYRATE COMPOUNDS FOR USE IN REDUCING LIVER FAT | TDELTAS LTD (GB) | 2026-01-08 | — | — | US | disclosed |
| EP-4644408-A1 | POLYETHYLENIMINE-MODIFIED CRY PROTEINS AND THEIR USE | The Chinese University of Hong Kong Office of Research and Knowledge Transfer Services (ORKTS) (HK) | 2025-11-05 | — | — | EP | disclosed |
| US-12439944-B2 | 3-hydroxybutyrate compounds for use in reducing liver fat | TDELTAS LIMITED (GB) | 2025-10-14 | — | — | US | disclosed |
| US-12370165-B2 | Hunger suppression | TDELTAS LIMITED (GB) | 2025-07-29 | — | — | US | disclosed |
| US-12290496-B2 | Compounds for use in preventing or treating athlete overtraining | TDELTAS LIMITED (GB) | 2025-05-06 | — | — | US | disclosed |
| US-12226387-B2 | Compounds for use in cancer cachexia | TDELTAS LIMITED (GB) | 2025-02-18 | — | — | US | disclosed |
| US-20070185346-A1 | Kit for automated resolving agent selection and method thereof | VAIDYA NITEEN A | 2007-08-09 | — | — | US | disclosed |
| US-6387934-B1 | RHEUMATIC DISEASES | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2002-05-14 | — | — | US | disclosed |
| US-6384228-B2 | EPIBATIDINE; ANALGESICS; ANIMAL EXTRACTS | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2002-05-07 | — | — | US | disclosed |
| US-20020010339-A1 | METHOD FOR SYNTHESIS OF HALOPYRIDYL-ACYCLOPENTANE DERIVATIVE AND INTERMEDIATE THEREOF | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2002-01-24 | — | — | US | disclosed |
| US-6172103-B1 | TREATING BONE DISORDERS, OSTEOPOROSIS, AND ARTHRITIS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2001-01-09 | — | — | US | disclosed |
| US-6121316-A | BONE DISORDERS | HOECHST AKTIENGESELLSCHAFT (DE) | 2000-09-19 | — | — | US | disclosed |
| EP-0829470-B1 | 2-Cyano-3,5-dihydroxy-hex-2-ene carboxamide derivatives, process for their preparation and their use as medicaments | HOECHST AG (DE) | 1999-12-15 | — | — | EP | disclosed |
| EP-0829470-A1 | 2-Cyano-3,5-dihydroxy-hex-2-ene carboxamide derivatives, process for their preparation and their use as medicaments | HOECHST AKTIENGESELLSCHAFT (DE) | 1998-03-18 | — | — | EP | disclosed |